Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis

Author:

Guo Kaixuan123ORCID,Shi Juanyi24,Tang Zhuang123,Lai Cong123,Liu Cheng123,Li Kuiqing123,Li Zhuohang123,Xu Kewei123ORCID

Affiliation:

1. Department of Urology Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University Guangzhou China

2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University Guangzhou China

3. Guangdong Provincial Clinical Research Center for Urological Diseases Guangzhou China

4. Department of Hepatobiliary Surgery Sun Yat‐Sen Memorial Hospital, Sun Yat‐Sen University Guangzhou China

Abstract

AbstractCircular RNAs (circRNAs) play crucial roles in various biological processes, including prostate cancer (PCa). However, the precise roles and mechanism of circRNAs are complicated. Hence, we studied the function of a circRNA that might be involved in the progression of PCa. In this study, we found that circARHGEF28 was frequently downregulated in PCa tissues and cell lines. Furthermore, gain‐ and loss‐of function experiments in vitro showed that circARHGEF28 inhibited proliferation, migration, and invasion of PCa. Additionally, circARHGEF28 suppressed PCa progression in vivo. Bioinformatics analysis and RNA pull‐down and capture assay found that circARHGEF28 sponged miR‐671‐5p in PCa cells. Importantly, qRT‐PCR and dual luciferase assays found that Lectin galactoside‐binding soluble 3 binding protein (LGALS3BP) was downstream of miR‐671‐5p, and western blot analysis further confirmed that LGALS3BP negatively regulated the nuclear factor kappa‐B (NF‐κB) pathway. These results demonstrated that circARHGEF28 abolished the degradation of LGALS3BP by sponging miR‐671‐5p, thus blocking the activation of the NF‐κB pathway. Our findings revealed that circARHGEF28/miR‐671‐5p/LGALS3BP/NF‐κB may be an important axis that regulates PCa progression.

Funder

Guangdong Science and Technology Department

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3